ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Paper Calls for More Diversity and Inclusivity in Neuroscientific Research

The perspective piece was published in ‘Nature Neuroscience’

For years, The Feinstein Institutes for Medical Research has been calling attention to the historical lack of diversity and inclusion in medical and scientific research. Now, a new perspective piece published today Nature Neuroscience underscores this urgent need, specifically highlighting the critical importance of inclusivity in human neuroscience studies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241227014566/en/

Dr. Elvisha Dhamala is the perspective’s corresponding author. (Credit: Feinstein Institutes)

Dr. Elvisha Dhamala is the perspective’s corresponding author. (Credit: Feinstein Institutes)

Corresponding author, Elvisha Dhamala, PhD, assistant professor in the Institute of Behavioral Sciences at the Feinstein Institutes, explains how factors like sex, gender, race, ethnicity and economic status can impact brain biology and behavior. Currently, many studies primarily include participants who are western, educated, industrialized, rich and democratic but the impact of this is that research findings may not apply to everyone. For example, mental illnesses can show up differently across various groups, and current research may not capture these differences. This paper argues that ignoring these differences can lead to inaccurate diagnoses and treatments. It also points out that excluding certain groups from research can worsen existing health disparities.

“Without diverse representation in human neuroscience research, we risk developing a skewed understanding of the brain and behavior,” said Dr. Dhamala. “This can lead to misdiagnosis, ineffective treatments, and ultimately, exacerbate health disparities for those already marginalized.”

The authors offer several recommendations for making scientific research more inclusive, including the following:

  • Recruitment: Researchers should recruit participants from diverse communities and avoid relying solely on university students. They should also work with community leaders and build diverse research teams.
  • Data Collection: Researchers need to collect information about participants' backgrounds using validated questionnaires and ensure that data collection methods are accessible to everyone. They should also provide support like transportation and childcare to make participation easier.
  • Data Analysis: Researchers should analyze data in ways that consider the impact of sociodemographic factors. They should also be careful not to oversimplify findings or make harmful generalizations about specific groups.

In the perspective, they stress that inclusive research is not optional and call on fellow researchers, institutions, and funding agencies to prioritize diversity and inclusion in all aspects of human biomedical research.

“As Dr. Dhamala's work shows, inclusive research is essential for understanding the human brain and building an equitable healthcare system,” said Anil K. Malhotra, MD, co-director of the Institute of Behavioral Science at the Feinstein Institutes. “We must prioritize diversity in biomedical research to ensure accurate diagnoses, personalized treatments, and health equity for all.”

Recent research from Dr. Dhamala also showed that sex and gender identity impact neurobiology. Using MRI scans to observe brain activity, they examined how sex and gender were linked to brain networks. The findings showed distinct patterns of brain activity were associated with sex assigned at birth and gender identity, particularly in brain regions associated with social cognition and emotional processing.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.